Puma SE Stock
€21.46
Your prediction
Puma SE Stock
Puma is a multinational sports clothing and accessories company that is listed on the Frankfurt Stock Exchange. The company is known for its innovative designs and high-quality products, particularly in the areas of footwear, apparel, and accessories for various sports such as football and running. Puma has a global presence, with operations in over 120 countries, and works closely with top athletes and sports teams to develop and promote its products. The company's stock has performed well in recent years, reflecting its strong financial performance and market position in the competitive sports industry.
Pros and Cons of Puma SE in the next few years
Pros
Cons
Performance of Puma SE vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Puma SE | 2.690% | 14.759% | 6.501% | -43.895% | -51.558% | -64.657% | -69.184% |
| V.F. Corp. | 1.240% | 10.638% | 20.264% | -22.229% | -37.225% | -68.786% | -77.334% |
| Prada SpA | 3.050% | 8.524% | -5.430% | -20.381% | -35.758% | -3.908% | 48.402% |
| Christian Dior S.A. | -1.110% | 3.118% | 6.063% | -22.998% | -19.533% | -23.487% | 33.518% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Puma SE, traded under the US symbol "PUM", currently showcases a financial landscape marked by steady performance and challenges typical within the Textiles & Apparel industry. An examination of its financial statements offers valuable insights into its profitability, liquidity, and overall financial health. Despite facing headwinds like declining revenue growth and increased operating expenses, Puma remains a formidable player in the sportswear market, backed by a solid balance sheet and notable metrics that highlight its potential.
Pros of Puma's Financials:
Strong Revenue Generation: With a total revenue of approximately €8.5 billion (about $8.8 billion) reported for the trailing twelve months, Puma maintains a significant presence in the market. Its gross profit of €3.9 billion suggests effective leverage of its sales, indicating a healthy gross profit margin of about 46%, showcasing the company’s ability to maintain strong product pricing.
Comments
News
Puma (PBYI) Q2 Revenue Rises 11%
Puma Biotechnology (NASDAQ:PBYI), a pharmaceutical company focused on therapies for cancer, released its second quarter 2025 earnings on August 7, 2025. The company posted non-GAAP earnings per
EQS-News: PUMA appoints Archie McEachern as Vice President Basketball
EQS-News: PUMA appoints Andreas Hubert as Chief Operating Officer